Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

U.S. oncology group rates blood cancer regimens, including cost
U.S. oncology group rates blood cancer regimens, including cost
The most influential source for U.
EC approves Basilea's isavuconazole to treat invasive aspergillosis and mucormycosis
EC approves Basilea's isavuconazole to treat invasive aspergillosis and mucormycosis
The European Commission (EC) has approved Basilea Pharmaceutica's isavuconazole (Cresemba) product to treat invasive aspergillosis and mucormycosis.
LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis
LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis
LEO Pharma Inc.
New Discovery About Fructose Could Lead To Treatments For Cancer, Obesity And Diabetes
New Discovery About Fructose Could Lead To Treatments For Cancer, Obesity And Diabetes
Scientists have discovered how one sugar – fructose – is transported into our cells.
AHF Calls on President Obama to Withdraw Dr. Robert Califf as Nominee to Head FDA
AHF Calls on President Obama to Withdraw Dr. Robert Califf as Nominee to Head FDA
LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), which previously criticized FDA Commissioner nominee Dr.
Obama nominates Robert Califf as FDA commissioner
Obama nominates Robert Califf as FDA commissioner
President Barack Obama has nominated Dr.
Baricitinib Demonstrates Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis in Pivotal Phase 3 Study
Baricitinib Demonstrates Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis in Pivotal Phase 3 Study
INDIANAPOLIS, IN, USA I October 14, 2015.
Savolitinib completes enrolment for Phase II clinical trial in Papillary Renal Cell Carcinoma
Savolitinib completes enrolment for Phase II clinical trial in Papillary Renal Cell Carcinoma
Shanghai.
Zafgen Issues Statement: Patient Died During Beloranib Trial
Zafgen Issues Statement: Patient Died During Beloranib Trial
BOSTON, Oct.
Valeant under US federal investigation over drug pricing
Valeant under US federal investigation over drug pricing
Canadian pharmaceutical group Valeant says it has received subpoenas from US federal prosecutors seeking information about the pricing and distribution of its drugs, along with how it makes them more ...
J&J says it has plenty of firepower for M&A, buyback or no buyback
J&J says it has plenty of firepower for M&A, buyback or no buyback
Johnson & Johnson ($JNJ) may be embarking on a $10 billion share repurchase program, but that doesn't mean it doesn't have room to make deals.
Danish malaria vaccine discovery provides potential cancer cure
Danish malaria vaccine discovery provides potential cancer cure
COPENHAGEN, Oct.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand